Table 4: Rate of Infections Per 100 Patient Years Under
Treatment with RTX in a Population Selected for a
High Risk of Serious Infection (I), a Registry (II)
and in a Meta-Analysis of Clinical Studies (III)
Data Source
Therapy
Infections/100 Patient Years
i.
ACURA Centre for Rheumatic Diseases 2011
RTX
9.5
ii.
AIR Registry, Gottenberg et al. 2010 (4)
RTX
5.0
iii.
Meta-analysis of clinical studies, van Vollenhoven et al. 2010 (3)